Cyclooxygenase-2 promotes early atherosclerotic lesion formation in ApoE-deficient and C57BL/6 mice
Michael E. Burleigh(Merck Canada Inc. (Canada)), MacRae F. Linton(Vanderbilt University), John Oates(The Open University), J MORROW(Vanderbilt University), Sergio Fazio(Alzheimer's Association), Amy S. Major(Vanderbilt University Medical Center), Jennifer L. McCaleb(Vanderbilt University Medical Center), Vladimir R. Babaev(Vanderbilt University Medical Center), Patricia G. Yancey(Vanderbilt University Medical Center)
Cited by 102
Related Papers
Increase in Circulating Products of Lipid Peroxidation (F<sub>2</sub>-Isoprostanes) in Smokers — Smoking as a Cause of Oxidative Damage
|New England Journal of Medicine|1995|1.3k
Current Perspectives on Statins
|Circulation|2000|1.2k
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2
|Nature|2007|732